The premier single priced GLP-1 provider in the game

At present, insurance coverage does not include virtual visits for our program. That being said, certain insurance plans might offer coverage for other expenses associated with medical weight loss treatment, including lab testing and prescription weight loss medication.

Our team consists of physicians and licensed nurse practitioners who possess the qualifications to prescribe medications, order lab tests, and evaluate your symptoms and health objectives. They are well-equipped to develop a personalized care plan tailored to your specific needs.

GLP-1 medications work by regulating appetite to reduce food intake. Studies have demonstrated their potential to achieve weight reductions of up to 15% in individuals who take them for a year or longer, in conjunction with healthy lifestyle choices*.

Weight loss is not solely reliant on willpower, as biological factors affecting metabolism, hunger, and weight can be beyond your control.

GLP-1s promote a prolonged feeling of fullness, help control food cravings, and enhance the body’s ability to process sugars more efficiently (source). Consequently, these medications are often prescribed for managing type 2 diabetes or obesity.

In chronic weight management, GLP-1 medications are sometimes utilized alongside a reduced-calorie diet and increased physical activity. They are also employed in patients with diabetes to assist in blood sugar management.

Examples of GLP-1 medications include:
‍
Semaglutide (Wegovy®, Rybelsus®, Ozempic®)
‍
Tirzepatide (Zepbound®, Mounjaro®), Dulaglutide (Trulicity®)
‍
Liraglutide (Victoza®, Saxenda®)

During your initial consultation, your provider will evaluate your health requirements to determine the suitability of medication for you. They will also address any inquiries you may have regarding GLP-1 medications.

*Note: It is always important to consult with your healthcare provider for personalized medical advice and treatment options.

Certainly! We offer maintenance therapy for patients in most cases, however, the only patients that don't qualify for maintenance therapy are patients with a BMI < 22 and this is mainly because we're a virtual platform and for this patient population it's safer to provide maintenance therapy if they're managed at a physical clinic. In order to qualify for maintenance therapy, a patient needs to have a previous diagnosis of obesity (BMI > 30) or overweight (BMI > 27) and have been on a GLP-1 medication within the past 12 months. You may take our quiz to see if you qualify for maintenance therapy!

If you meet any of the following criteria, you may not be eligible for a prescription of GLP-1 weight loss medication:

1. Currently pregnant, breastfeeding, or actively trying to become pregnant
2. End-stage kidney disease (on or about to be on dialysis)
3. End-stage liver disease (cirrhosis)
4. Active eating disorder or history of eating disorder (bulimia, anorexia, etc.)
5. Current suicidal thoughts and/or prior suicidal attempt
6. Cancer (active diagnosis or treatment)
7. Current or history of pancreatitis
8. History of organ transplant on anti-rejection medication
9. Severe gastrointestinal condition (gastroparesis, inflammatory bowel disease)
10. Personal or family history of medullary thyroid cancer or multiple endocrine neoplasia (MEN) type 2

Please note that these eligibility criteria are not exhaustive, and it is crucial to consult with your healthcare provider for a comprehensive assessment of your individual circumstances.